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SARCOID CARDIOMYOPATHY
Sivakumar Srinivasan, MD and Emanuel Chryssos, MD
The patient is a 40 year old African-American female with no
significant past medical history who presented to the ED with a 2
week history of lower extremity edema and shortness of breath.
She also noticed intermittent palpitations, dry cough, easy fatigue
and a 30 pound weight loss. On examination, the patient’s
temperature was 98.9F orally, pulse was 155-170 beats per
minute, and blood pressure was 133/93 mmHg. EKG revealed
long P-R tachycardia with heart rate of 170. Chest X- ray was
done and showed large right pleural effusion with compressive
atelectasis and small left pleural effusion. Transthoracic echocardiogram at the time of admission was consistent with severe global
LV dysfunction with EF-20% and moderate pulmonary
hypertension. CT Chest, which showed bilateral hilar adenopathy
and subsequent biopsy was consistent with non-caseating
granulomatous lesion. Her initial basic laboratory values,
including TSH level, were normal except for BNP which was 569.
She underwent left and right heart catheterization, which revealed
normal coronary arteries and decreased cardiac index. During the
hospital stay, telemetry monitors revealed rhythms consistent with
various degrees of AV conduction abnormalities. She was started
on steroids and intravenous milrinone for possible sarcoid
cardiomyopathy and listed for heart transplant. Her symptoms
were gradually improved and she was discharged home with
steroids, beta blockers, diuretics, ace inhibitors and an implantable
defibrillator. She is currently followed as an outpatient and doing
extremely well without any cardiac symptoms.

Myocardial sarcoidosis may have restrictive as well as congestive
features because cardiac infiltration by sarcoid granulomas results
not only in increased stiffness of the ventricular wall but also in
diminished systolic contractile function. Occasionally patients
with extensive involvement of the left ventricular myocardium
develop left ventricular aneurysms; it has been suggested that
corticosteroid treatment may convert granulomas to scar tissue
and contribute to the development of aneurysmal dilatation. Firstdegree heart block due to disease of AV Node or bundle of His,
and various types of intraventricular conduction defects, are
common among patients with cardiac sarcoidosis. Complete heart
block is the most common finding in patients with clinically
evident cardiac sarcoidosis, and occurs at a younger age in patients
with sarcoidosis than in individuals with complete heart block
due to other etiologies. Corticosteriods can be used to halt
progression of disease, but it has little to no benefit once EF is
<30%. Heart transplantation for sarcoidosis with advanced heart
failure has been performed less commonly than lung transplantation. Survival has been similar to that of patients undergoing
heart transplantion for other indications. Despite the possibility
of recurrence of sarcoidosis in the graft or the appearance of
progressive extracardiac disease, available evidence supports
transplantation for cardiac sarcoidosis in patients with extensive
cardiac involvement and advanced heart failure as long as there is
minimal extracardiac involvement.
■
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Figure 1. Hematoxylin and
Eosin stain of lymph node at
low power magnification
showing multiple noncaseating granulomas.
(arrows)
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Figure 2. Higher power
magnification reveals lack of
necrotic material within the
granuloma. Also seen is peri granulomatous connective tissue
(arrow) consistent with fibrosis
which can sometimes be a marker
of long-standing sarcoid.
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IMAGE IN MEDICINE
Amy Baranoski, MD
Pictured here is the back of a man with leprosy who had been
treated at Acworth Leprosy Hospital in Mumbai, India. Note the
diffuse, macular, hypopigmented rash. Leprosy is a chronic disease
caused by infection with Mycobacterium leprae. The disease can
affect a variety of organs including peripheral nerves, skin, muscle,
eye, bone, and testes. Leprosy is diagnosed clinically by the
presence of at least one of the following: hypopigmented patches,
loss of cutaneous sensation, thickened nerves, and acid-fast bacilli
in nasal or skin smears.
The prevalence of leprosy has decreased worldwide due to multidrug therapy and public health programs focused on education
and detection of the illness. Multi-drug therapy consists of the
bactericidal drugs: rifampin, dapsone, clofazimine, ethionamide
and protionamide. Quinolones, minocycline, and clarithromycin
are not part of the normal regimen, but can be combined with
rifampin, primarily in single lesion leprosy.
■

In November 2005 Dr. Baranoski
spent several weeks observing
various clinics and hospitals in
Mumbai, India where she
captured the following image.
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